Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?
Journal of Hepatology · 2024
DOI: 10.1016/j.jhep.2023.09.034 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Hepatology, 2024. Verfasst von Meng Sha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: simonsha2…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: simonsha23@163.com.
- Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
- Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: xiaqiang@shsmu.edu.cn.
Zitieren
APA
Sha, M., Cao, J., & Xia, Q. (2024). Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2023.09.034
Vancouver
Sha M, Cao J, Xia Q. Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?. Journal of Hepatology. 2024. doi:10.1016/j.jhep.2023.09.034
BibTeX
@article{Sha2024,
author = {Sha, Meng and Cao, Jie and Xia, Qiang},
title = {Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: What are the optimal criteria?},
journal = {Journal of Hepatology},
year = {2024},
doi = {10.1016/j.jhep.2023.09.034}
}
EUVIMED